SCHEMBL6498528

SCHEMBL6498528

CC(C)(Sc1cc[c]c(Cl)c1Cl)C(N)=O

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 5/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
PPARA Q07869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6503743 0.71
SCHEMBL6244342 0.68
SCHEMBL6496406 0.64
SCHEMBL6497751 0.64
SCHEMBL6498524 0.61 CA2 (0.33) MAPTKMT2A
SCHEMBL6496797 0.61 THRB (0.33) KMT2A
SCHEMBL6499187 0.60 THRB (0.38) MAPTKMT2A
SCHEMBL18527595 0.59
SCHEMBL16925206 0.58 SIRT1 (0.41) MAPTKMT2A
SCHEMBL1969487 0.58 ALDH1A1 (0.42) MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed